Clinical Trial Update: Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing BCD-131 to Mircera in anemia treatment for CKD patients on dialysis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• BCD-131
• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Biocad | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2019-07-26